An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma.
Saved in:
| Title: | An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma. |
|---|---|
| Authors: | Beckett EM; Benchmark Risk Group, Boston, MA, USA., Abelmann A; Benchmark Risk Group, Chicago, IL, USA., Roberts B; Benchmark Risk Group, Grand Rapids, MI, USA., Lewis RC; Benchmark Risk Group, Oakland, CA, USA., Cheatham D; Benchmark Risk Group, Chicago, IL, USA., Miller EW; Benchmark Risk Group, Grand Rapids, MI, USA., Hall E; Benchmark Risk Group, Grand Rapids, MI, USA., Pierce JS; Benchmark Risk Group, Chicago, IL, USA. |
| Source: | Critical reviews in toxicology [Crit Rev Toxicol] 2023 Nov; Vol. 53 (10), pp. 611-657. Date of Electronic Publication: 2023 Dec 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1547-6898 (Electronic) Linking ISSN: 10408444 NLM ISO Abbreviation: Crit Rev Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1547-6898 |
|---|---|
| DOI: | 10.1080/10408444.2023.2283169 |
